Dr Beth Ann Rasmussen, MD | |
25 Prospect Cir, Troy, MO 63379-3173 | |
(636) 528-2650 | |
(636) 528-2661 |
Full Name | Dr Beth Ann Rasmussen |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 25 Prospect Cir, Troy, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568544278 | NPI | - | NPPES |
209265602 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 2004015919 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Beth Ann Rasmussen, MD 25 Prospect Cir, Troy, MO 63379-3173 Ph: (636) 528-2650 | Dr Beth Ann Rasmussen, MD 25 Prospect Cir, Troy, MO 63379-3173 Ph: (636) 528-2650 |
News Archive
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Substance abuse is a major public health problem in the United States, with some 21 million Americans diagnosed with at least one substance use disorder.
Researchers say they have definitively confirmed that there is a link between the sickle cell trait and sudden cardiac death in African–American athletes.
Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the neuropathic pain drug market - driven by the launches of several novel therapies - will increase from $6 billion in 2008 to $9.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 7 days ago